TransMedics Group, Inc. (TMDX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 20.00M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.46B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $20.00M | (m) | (m) | (m) | $1.46B | (m) |
| 2026-03-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | $1.43B | (m) |
| 2025-12-31 | (m) | (m) | $10.00M | (m) | (m) | (m) | $1.07B | (m) |
| 2025-09-30 | (m) | (m) | $5.00M | (m) | (m) | (m) | $946.03M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $58.80M | (m) | (m) | $287.09M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $58.70M | (m) | (m) | $277.15M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $58.54M | (m) | (m) | $274.87M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $35.48M | (m) | $58.08M | $117.28M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $35.33M | (m) | $72.00M | $124.01M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $35.20M | (m) | $92.45M | $134.89M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $35.06M | (m) | $102.86M | $131.15M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $34.92M | (m) | $112.25M | $140.51M | (m) |
| 2021-03-31 | (m) | (m) | $0.00 | $34.79M | (m) | $118.11M | $145.78M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $34.66M | (m) | $125.64M | $152.03M | (m) |
| 2020-09-30 | (m) | (m) | $0.00 | $34.52M | (m) | $132.71M | $159.32M | (m) |
| 2020-06-30 | (m) | (m) | $0.00 | $34.40M | (m) | $139.38M | $163.14M | (m) |
| 2020-03-31 | (m) | (m) | $0.00 | $34.27M | (m) | $72.55M | $96.92M | (m) |
| 2019-12-28 | (m) | (m) | (m) | $34.15M | (m) | $80.69M | $105.30M | (m) |
| 2019-09-28 | (m) | (m) | (m) | $34.02M | (m) | $88.27M | $112.62M | (m) |
| 2019-06-29 | (m) | (m) | (m) | $33.90M | (m) | $96.24M | $121.01M | (m) |
| 2019-03-30 | (m) | (m) | (m) | $33.78M | (m) | (m) | $38.76M | (m) |
| 2018-12-29 | (m) | (m) | (m) | $33.67M | (m) | (m) | $42.16M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |